当前位置: 首页 > 详情页

Neuroinflammation in Vascular Cognitive Impairment and Dementia: Current Evidence, Advances, and Prospects

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Capital Med Univ, Beijing Adv Innovat Ctr Big Data Based Precis Med, Beijing Inst Brain Disorders,Lab Brain Disorders, Minist Sci & Technol,Collaborat Innovat Ctr Brain, Beijing 100069, Peoples R China [2]Capital Med Univ, Xuanwu Hosp, Dept Neurosurg, Beijing 100069, Peoples R China
出处:
ISSN:

关键词: hypoxia ischemia microglia neuroinflammation vascular cognitive impairment and dementia

摘要:
Vascular cognitive impairment and dementia (VCID) is a major heterogeneous brain disease caused by multiple factors, and it is the second most common type of dementia in the world. It is caused by long-term chronic low perfusion in the whole brain or local brain area, and it eventually develops into severe cognitive dysfunction syndrome. Because of the disease's ambiguous classification and diagnostic criteria, there is no clear treatment strategy for VCID, and the association between cerebrovascular pathology and cognitive impairment is controversial. Neuroinflammation is an immunological cascade reaction mediated by glial cells in the central nervous system where innate immunity resides. Inflammatory reactions could be triggered by various damaging events, including hypoxia, ischemia, and infection. Long-term chronic hypoperfusion-induced ischemia and hypoxia can overactivate neuroinflammation, causing apoptosis, blood-brain barrier damage and other pathological changes, triggering or aggravating the occurrence and development of VCID. In this review, we will explore the mechanisms of neuroinflammation induced by ischemia and hypoxia caused by chronic hypoperfusion and emphasize the important role of neuroinflammation in the development of VCID from the perspective of immune cells, immune mediators and immune signaling pathways, so as to provide valuable ideas for the prevention and treatment of the disease.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2021]版:
大类 | 2 区 生物学
小类 | 3 区 生化与分子生物学 3 区 化学综合
最新[2023]版:
大类 | 2 区 生物学
小类 | 3 区 生化与分子生物学 3 区 化学:综合
JCR分区:
出版当年[2020]版:
Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Q2 CHEMISTRY, MULTIDISCIPLINARY
最新[2023]版:
Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Q2 CHEMISTRY, MULTIDISCIPLINARY

影响因子: 最新[2023版] 最新五年平均 出版当年[2020版] 出版当年五年平均 出版前一年[2019版] 出版后一年[2021版]

第一作者:
第一作者机构: [1]Capital Med Univ, Beijing Adv Innovat Ctr Big Data Based Precis Med, Beijing Inst Brain Disorders,Lab Brain Disorders, Minist Sci & Technol,Collaborat Innovat Ctr Brain, Beijing 100069, Peoples R China
通讯作者:
通讯机构: [1]Capital Med Univ, Beijing Adv Innovat Ctr Big Data Based Precis Med, Beijing Inst Brain Disorders,Lab Brain Disorders, Minist Sci & Technol,Collaborat Innovat Ctr Brain, Beijing 100069, Peoples R China [2]Capital Med Univ, Xuanwu Hosp, Dept Neurosurg, Beijing 100069, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16461 今日访问量:0 总访问量:871 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院